Table 1.
Top 10 pharmaceutical products by Global sales in 2017 (million U.S. dollars).
| Rank | Product | Therapeutic Subcategory | Vendor Company | Originator | 2017 Sales ($m) |
|---|---|---|---|---|---|
| 1 | Humira | Other anti-rheumatics | AbbVie, Eisai | Knoll | 18,923 |
| 2 | Enbrel | Other anti-rheumatics | Amgen, Pfizer, Takeda | Immunex, acquired by Amgen | 8,234 |
| 3 | Revlimid | Other cytostatics | Celgene, BeiGene | Celgene | 8,211 |
| 4 | Rituxan | Anti-neoplastic MAbs | Roche | IDEC Pharmaceuticals, merged with Biogen | 7,528 |
| 5 | Remicade | Other anti-rheumatics | Johnson & Johnson, Merck & Co, Mitsubishi Tanabe Pharma | Centocor, renamed Janssen Pharmaceutical | 7,172 |
| 6 | Herceptin | Anti-neoplastic MAbs | Roche | Genentech | 7,126 |
| 7 | Avastin | Anti-neoplastic MAbs | Roche | Genentech | 6,795 |
| 8 | Eylea | Eye/Ophthalmic preparations | Regeneron Pharmaceuticals, Bayer, Santen Pharmaceutical | Regeneron Pharmaceuticals | 6,291 |
| 9 | Opdivo | Anti-neoplastic MAbs | Bristol-Myers Squibb, Ono Pharmaceutical | Ono Pharmaceutical | 5,761 |
| 10 | Prevnar 13 | Vaccines | Pfizer | Wyeth | 5,693 |
Source: Evaluate Ltd. "Top 100 Products in 2024″